TORONTO STOCK EXCHANGE · BCTX
-1.62% · -$0.0600 · Vol 158.0K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Briacell Therapeutics Corp

Briacell Therapeutics Corp

Biotechnology
$3.64
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BCTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for BCTX are being assembled.
About Briacell Therapeutics Corp
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
4
Country
CA

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.70
Day high
$3.83
Day low
$3.58
Previous close
$3.70
52W high
$3.83
-4.96% from high
52W low
$2.68
83% of range
Market cap
$32.2M
EPS
$-9.5600
Shares out
8.7M
Volume
158K
VWAP
$3.67
Price history computed in-house
1W
+4.30%
1M
+35.82%
SMA 50 $3.10 · above
SMA 200 $3.10 · above
52W position 83%
Veridion warehouse edge

Warehouse intelligence for BCTX.

Veridion Score
52
0: 891: 522: 383: 204: 755: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BCTX insider activity

Briacell Therapeutics Corp

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BCTX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BCTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BCTX in this window.
Lobbying spend

BCTX lobbying filings, year to date.

Registered lobbying filings matched to Briacell Therapeutics Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BCTX in this window.
Latest news · BCTX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BCTX.
Options
Sovereign unlock shows live options positioning for BCTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.